REG - Morgan Stanley Cap - Rule 38.5 - ABBVIE INC.

Morgan StanleyAnnouncement

30/03/2020 11:40

RNS Number : 0347I
  
Morgan Stanley Capital Services LLC
  
30 March 2020
  
 

 
 FORM 38.5 
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)
 
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
 
1.             KEY INFORMATION




 Name of exempt market-maker


  Morgan Stanley Capital Services LLC




 Company dealt in


  ABBVIE INC.




 Class of relevant security to which the dealings being disclosed relate (Note 1)


  US$0.01 COMMON STOCK




 Date of dealing


  27 MARCH 2020




 
 
2.             DEALINGS (Note 2)
 
(a)           Purchases and sales




 Total number of relevant secuities accquired


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  14,343


 74.8100 USD


 70.8200 USD




 




 Total number of relevant secuities disposed


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  23,622


 74.9400 USD


 70.9000 USD




 
 
(b)           Derivatives transactions (other than options transactions)
 




 Product name, e.g. CFD


 Nature of transaction 
                (Note 4)


 Number of relevant securities 
                (Note 5)


 Price per unit




 CFD


 LONG


 4,330


 72.4367 USD




 CFD


 LONG


 200


 72.6700 USD




 CFD


 LONG


 177


 72.6700 USD




 CFD


 LONG


 347


 73.3580 USD




 CFD


 LONG


 53


 73.3580 USD




 CFD


 LONG


 7,794


 73.5402 USD




 CFD


 LONG


 3,724


 73.6555 USD




 CFD


 LONG


 693


 73.6621 USD




 CFD


 LONG


 513


 73.8094 USD




 CFD


 LONG


 234


 73.8256 USD




 CFD


 LONG


 23


 73.8300 USD




 CFD


 LONG


 300


 74.0037 USD




 CFD


 LONG


 100


 74.0037 USD




 CFD


 LONG


 500


 74.0520 USD




 CFD


 LONG


 1,000


 74.0620 USD




 CFD


 LONG


 3,300


 74.1323 USD




 CFD


 SHORT


 111


 70.8333 USD




 CFD


 SHORT


 200


 71.8690 USD




 CFD


 SHORT


 300


 72.4233 USD




 CFD


 SHORT


 402


 72.6700 USD




 CFD


 SHORT


 608


 73.0720 USD




 CFD


 SHORT


 300


 73.2167 USD




 CFD


 SHORT


 482


 73.2672 USD




 CFD


 SHORT


 3,464


 73.6445 USD




 CFD


 SHORT


 23


 73.8300 USD




 
 
(c)            Options transactions in respect of existing relevant securities
 
i)           Writing, selling, purchasing or varying
 




 Product name, eg call option


 Writing, selling, purchasing, varying etc


 Number of securities to which the option relates (Note 5)


 Exercise Price


 Type, e.g American, European etc 


 Expiry Date 


 Option money paid/received per unit (Note 3)




 N/A


 N/A


 N/A


 N/A


 N/A


 N/A


 N/A 




 
(ii) Exercising
 




 Product name, eg call option


 Number of securities


 Exercise price per unit (Note 3)




 N/A


 N/A


 N/A  




 
 
3. OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 




Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 




 
 
 
 
 




 
 




 Date of disclosure


30 MARCH 2020




 Contact Name


Craig Horsley




 Telephone Number


+44(141) 245 7736 




 Name of offeree/offeror with which connected


ABBVIE INC. 




Nature of connection (Note 6)


Advisory 




 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ISEUROKRROUOORR